Bulletin
Investor Alert

New York Markets Open in:

23andMe Holding Co.

NAS: ME

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

Dec 1, 2021, 7:50 a.m.

ME
/zigman2/quotes/222659849/composite

$

8.48

Change

+0.26 +3.16%

Volume

Volume 2,079

Real time quotes

/zigman2/quotes/222659849/composite

Previous close

$ 8.22

$ 8.22

Change

-0.63 -7.12%

Day low

Day high

$7.87

$8.95

Open

52 week low

52 week high

$7.01

$18.16

Open

Richard H. Scheller

Richard H. Scheller holds the position of Chairman at DiCE Therapeutics, Inc, Chairman for DICE Molecules SV, Inc. (a subsidiary of DiCE Therapeutics, Inc) and Director, Chairman-Research & Development at BridgeBio Pharma, Inc., Director, Chairman-Research & Development at BridgeBio Pharma LLC (a subsidiary of BridgeBio Pharma, Inc.). Richard H. Scheller is also Member of National Academy of Sciences, Member of American Academy of Arts & Sciences and Member of National Academy of Medicine of United States and on the board of 10 other companies.

He previously was Head-Genentech Research & Early Development at Roche Holding AG and Executive VP-Research & Early Development at Genentech, Inc. (a subsidiary of Roche Holding AG), Director & Chief Scientific Officer at Medrio, Inc. and Associate Professor at Stanford University.

He received a doctorate from California Institute of Technology, a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Wisconsin.

Transactions

Date Shares Transaction Value
09/14/2021 18,421   Award at $0 per share. 0

Officers and Executives

Ms. Anne E. Wojcicki
Chief Executive Officer & Director
Mr. Steven Schoch
Chief Financial & Accounting Officer
Mr. Steve Lemon
Vice President-Engineering
Dr. Joyce Tung
Vice President-Research
Dr. L. Okey Onyejekwe
VP-Healthcare Operations & Medical Affairs
Dr. Kenneth J. Hillan
Head-Therapeutics
Mr. Adam Auton
Vice President-Human Genetics
Mr. David Baker
Chief Security Officer
Dr. Arnab Chowdry
Vice President-Genetic Technology
Ms. Jacquie Cooke Haggarty
VP, Deputy General Counsel & Privacy Officer
Mr. Kent Hillyer
Vice President-Customer Care
Mr. Kumar Iyer
Head-Product
Dr. Jennifer Low
Head-Therapeutics Development
Mr. Mike Polcari
Vice President & Chief Architect
Dr. William Richards
Vice President-Drug Discovery
Dr. Monica Viziano
VP-Portfolio Strategy & Alliance Management
Mr. Evan M. Lovell
Director
Dr. Richard H. Scheller
Director
Ms. Tracy Keim
Vice President-Consumer Marketing & Brand
Ms. Elvia Cowan
Vice President & Controller
Dr. D. Wade Walke
Vice President-Investor Relations
Mr. Fred Kohler
Vice President-People
Ms. Kathy L. Hibbs
Secretary, Chief Legal & Regulatory Officer
Mr. Roelof Frederik Botha
Independent Director
Mr. Patrick Shuao-Fong Chung
Independent Director
Mr. Neil Mohan
Independent Director
Mr. Peter J. Taylor
Independent Director
Dr. Valerie Montgomery Rice
Independent Director
Dr. Sandra Rae Hernández
Independent Director
Link to MarketWatch's Slice.